Cargando…
Alpha-interferon does not increase the efficacy of 5-fluorouracil in advanced colorectal cancer
Two meta-analyses were conducted to quantify the benefit of combining α-IFN to 5FU in advanced colorectal cancer in terms of tumour response and survival. Analyses were based on a total of 3254 individual patient data provided by principal investigators of each trial. The meta-analysis of 5FU ± LV v...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363786/ https://www.ncbi.nlm.nih.gov/pubmed/11237380 http://dx.doi.org/10.1054/bjoc.2000.1669 |
Ejemplares similares
-
A randomized phase II trial of 5-fluorouracil, with or without human interferon-β, for advanced colorectal cancer
por: Villar-Grimalt, A, et al.
Publicado: (1999) -
Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer
por: Chau, I, et al.
Publicado: (2001) -
Continuous infusion of 5-fluorouracil with alpha 2b interferon for advanced colorectal carcinoma.
por: Ferguson, J. E., et al.
Publicado: (1995) -
The effect of 5-fluorouracil and alpha interferon and 5-fluorouracil and leucovorin on cellular anti-tumour immune responses in patients with advanced colorectal cancer.
por: Nichols, P. H., et al.
Publicado: (1994) -
Induction of thymidine phosphorylase as a pharmacodynamic end-point in patients with advanced carcinoma treated with 5-fluorouracil, folinic acid and interferon alpha
por: Braybrooke, J P, et al.
Publicado: (2000)